1. Home
  2. TANH vs INDP Comparison

TANH vs INDP Comparison

Compare TANH & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tantech Holdings Ltd.

TANH

Tantech Holdings Ltd.

N/A

Current Price

$0.83

Market Cap

6.2M

Sector

N/A

ML Signal

N/A

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TANH
INDP
Founded
2001
2000
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
5.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
TANH
INDP
Price
$0.83
$1.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
216.0K
95.0K
Earning Date
05-15-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.88
N/A
Revenue
$41,982,988.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$1.65
52 Week High
$5.86
$47.60

Technical Indicators

Market Signals
Indicator
TANH
INDP
Relative Strength Index (RSI) 31.67 30.84
Support Level $0.73 $2.60
Resistance Level $1.06 $2.66
Average True Range (ATR) 0.09 0.28
MACD -0.02 -0.13
Stochastic Oscillator 22.20 1.90

Price Performance

Historical Comparison
TANH
INDP

About TANH Tantech Holdings Ltd.

Tantech Holdings Ltd manufactures bamboo charcoal-based products. The company, through its subsidiaries, is engaged in the production and distribution of household products along with a trading business, which involves the export of charcoal products. It also manufactures electric double-layer capacitors carbon materials and low-emission barbecue charcoal. Its product portfolio includes air purifiers and humidifiers, underfloor humidity control, pillows and mattresses, wardrobe deodorizers, mousepads, and wrist mats, refrigerator deodorant, and charcoal toilet cleaner disks. The company has two reportable segments: the Consumer Product segment, and the Electric Vehicle (EV) segment.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: